National Institutes of Health
Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)
Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, closing January 10, 2028.
Overview
The overall goal of the Stimulating Access to Research in Residency (StARR) program is to provide resident clinicians in training with in-depth research experiences early in their careers, in order to recruit, retain and accelerate independence of a pool of clinician-investigators with both clinical and research…